Tissue-Resident Memory T Cells: Key to Improving Survival in Lung Cancer

Recent research from the Terasaki Institute reveals that tissue-resident memory T cells play a crucial role in the prognosis of non-small cell lung cancer (NSCLC). This groundbreaking study, published in Frontiers in Immunology, introduces an 18-gene risk score that predicts patient survival and aids in personalized treatment planning. By understanding the immune microenvironment, this research paves the way for improved therapies and highlights the potential of these immune cells as prognostic markers in lung cancer.